MannKind Execs to Engage Investors at Two Miami Healthcare Conferences
Event summary
- MannKind CEO Michael Castagna and CFO Chris Prentiss to participate in fireside chats and 1x1 investor meetings at two Miami conferences.
- Leerink Partners 2026 Global Healthcare Conference on March 10 at 3:40 p.m. ET.
- Barclays 28th Annual Global Healthcare Conference on March 11 at 1:00 p.m. ET.
- Live audio webcasts available on MannKind's investor relations website, with recordings accessible for 90 days post-conference.
The big picture
MannKind's participation in two high-profile healthcare investor conferences underscores its push to engage with the investment community amid a competitive biopharmaceutical landscape. The company's focus on cardiometabolic and orphan lung diseases positions it in niche but growing markets, where strategic messaging and investor confidence will be critical for future funding and partnerships.
What we're watching
- Strategic Messaging
- How MannKind's executives will position the company's focus on cardiometabolic and orphan lung diseases amid competitive pressures.
- Investor Sentiment
- Whether the 1x1 meetings will reveal new investor concerns or opportunities following recent financial performance.
- Pipeline Updates
- The pace at which MannKind will discuss progress in its drug-device combination therapies during these conferences.